Cargando…
Impaired LXRα Phosphorylation Attenuates Progression of Fatty Liver Disease
Non-alcoholic fatty liver disease (NAFLD) is a very common indication for liver transplantation. How fat-rich diets promote progression from fatty liver to more damaging inflammatory and fibrotic stages is poorly understood. Here, we show that disrupting phosphorylation at Ser196 (S196A) in the live...
Autores principales: | Becares, Natalia, Gage, Matthew C., Voisin, Maud, Shrestha, Elina, Martin-Gutierrez, Lucia, Liang, Ning, Louie, Rikah, Pourcet, Benoit, Pello, Oscar M., Luong, Tu Vinh, Goñi, Saioa, Pichardo-Almarza, Cesar, Røberg-Larsen, Hanne, Diaz-Zuccarini, Vanessa, Steffensen, Knut R., O’Brien, Alastair, Garabedian, Michael J., Rombouts, Krista, Treuter, Eckardt, Pineda-Torra, Inés |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344342/ https://www.ncbi.nlm.nih.gov/pubmed/30673619 http://dx.doi.org/10.1016/j.celrep.2018.12.094 |
Ejemplares similares
-
The nuclear receptor LXR modulates interleukin-18 levels in macrophages through multiple mechanisms
por: Pourcet, Benoit, et al.
Publicado: (2016) -
2290: Control of atherosclerosis regression by LXRα S198 phosphorylation
por: Shrestha, Elina, et al.
Publicado: (2018) -
Understanding the Effect of Statins and Patient Adherence in Atherosclerosis via a Quantitative Systems Pharmacology Model Using a Novel, Hybrid, and Multi-Scale Approach
por: Pichardo-Almarza, Cesar, et al.
Publicado: (2017) -
From PK/PD to QSP: Understanding the Dynamic Effect of Cholesterol-Lowering Drugs on Atherosclerosis Progression and Stratified Medicine
por: Pichardo-Almarza, Cesar, et al.
Publicado: (2016) -
Inhibiting LXRα phosphorylation in hematopoietic cells reduces inflammation and attenuates atherosclerosis and obesity in mice
por: Voisin, Maud, et al.
Publicado: (2021)